Atlas Trials

A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma

Clinical trial NCT05013801 · COMPLETED

Trial details

NCT number
NCT05013801
Sponsor
Unilever R&D
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Melasma
Start date
2021-09-06
Primary completion
2022-02-25
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.